Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

New York Presbyterian Hospital - Weill-Cornell, New York

Mount Sinai Hospital, New York

Thomas Jefferson University, Philadelphia

Virginia Commonwealth University, Richmond

Duke University Medical Center, Durham

Carolinas Healthcare System, Charlotte

MUSC Hollings Cancer Center, Charleston

Vanderbilt Ingram Cancer Center, Nashville

Cleveland Clinic, Cleveland

University of Cincinnati, Cincinnati

University of Nebraska Medical Center, Omaha

University of Texas Southwestern Medical Center, Dallas

Methodist Healthcare System, San Antonio

Colorado Blood Cancer Institute, Denver

University of California Los Angeles, Los Angeles

City of Hope, Duarte

McGill University, Montreal